City Holding Co. Details Executive Compensation, Board Nominees, and Shareholder Proposals for Annual Meeting
CHCO sits 17% above its 52-week low of $102.22.
Summary
City Holding Co. filed its definitive proxy statement for the upcoming April 29, 2026 Annual Meeting, detailing executive compensation for 2025, including significant performance-based payouts and substantial change-of-control severance packages, alongside board director nominees.
Key Events · Corporate Governance and Compliance · CHCO
-
Annual Shareholder Meeting Scheduled
The Annual Meeting of Shareholders is set for April 29, 2026, with a record date of March 16, 2026. Shareholders will vote on director elections, auditor ratification, and executive compensation.
-
New Director Nominee Introduced
B. Scott Raynes, President and CEO of Marshall Health Network, has been nominated as a Class II director to serve a two-year term, joining four Class III director nominees for re-election.
-
Detailed 2025 Executive Compensation Disclosed
The company reported strong 2025 financial performance, including $130.5 million in net income and a 21.2% ROATCE, leading to executive cash incentives at 190% of targeted payout levels. The CEO's total compensation was $1,922,194, resulting in a 42x pay ratio to the median employee.
-
Substantial Change-of-Control Severance Packages
Named executive officers have significant post-employment benefits, with CEO Charles R. Hageboeck having a fully vested termination benefit of $1,534,017 and a potential total payout of $5,769,394 in a change-of-control scenario.
Analysis · CHCO · Finance
This definitive proxy statement provides investors with crucial insights into City Holding Co.'s corporate governance and executive compensation practices ahead of its Annual Meeting. The detailed 2025 compensation report highlights strong performance-based incentives, reflecting the company's record net income and superior ROAA/ROATCE compared to peers. However, the disclosure of substantial change-of-control severance benefits for named executive officers, particularly the CEO's potential $5.77 million payout, represents a material financial consideration for shareholders in potential M&A scenarios. The election of directors, including a new nominee, and the advisory vote on executive compensation are standard annual agenda items, but the comprehensive financial and governance data presented is vital for assessing management alignment and potential liabilities.
At the time of this filing, CHCO was trading at $119.99 on NASDAQ in the Finance sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $102.22 to $133.59. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.